The combination of clinical parameters and immunophenotyping of intraepithelial lymphocytes allows to assess disease severity in refractory celiac disease
- 15 July 2022
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 54 (12) , 1649-1656
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (GRK2318, TRR241)
This publication has 23 references indexed in Scilit:
- ACG Clinical Guidelines: Diagnosis and Management of Celiac DiseaseAmerican Journal of Gastroenterology, 2013
- EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferationsLeukemia, 2012
- Origin and immunophenotype of aberrant IEL in RCDII patientsMolecular Immunology, 2012
- The Oslo definitions for coeliac disease and related termsGut, 2012
- Evaluation of Cladribine treatment in refractory celiac disease type IIWorld Journal of Gastroenterology, 2011
- Accurate classification of RCD requires flow cytometryGut, 2010
- Aberrant T‐lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localizationCytometry Part B: Clinical Cytometry, 2009
- Clinical Staging and Survival in Refractory Celiac Disease: A Single Center ExperienceGastroenterology, 2009
- Patchy villous atrophy in adult patients with suspected gluten-sensitive enteropathy: is a multiple duodenal biopsy strategy appropriate?Endoscopy, 2007
- Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936Leukemia, 2003